From: Spousal diabetes as a diabetes risk factor: A systematic review and meta-analysis
Author, Year | Study design, time frame | City, Country | Age limits; mean age (years; SD) | Source population; number | Couples, number | Method of identifying diabetes | Diabetes prevalencea; number (%) | Marriage duration, years | Effect estimates (Odds ratio (95% CI) unless otherwise stated) | Other variables used to adjust effect estimates | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Husbands | Wives | Not adjusted for BMI | Adjusted for BMI | |||||||||
Stimpson, 2005 | Cross- sectional; 1993-1994 | Southwest USA | ≥65;73.9 (6.3) for men; 70.9 (5.2) for women | Hispanic established populations for the epidemiologic studies of the elderly; 3,050 | 503 | Self-report | 25 (4.5) | 24 (4.3) | Unclear | 1.64 (1.07-2.54) women as outcome; 1.77 (1.14-2.74) men as outcome | 1.53 (0.98-2.39) women as outcome; 1.78 (1.14-2.79) men as outcome | Men’s age, education, nativity, blood pressure, smoking status and alcohol intake |
Jurj, 2006 | Cross-sectional; 1997-2000 | Shanghai, China | 40-70; 54.6 (9.7) for men;51.9 (8.8) for women | Shanghai Women’s health Study between; 74,943 women | 66,130 | Self-report | 2,689 (4.5); age-adjusted | 2,469 (3.4); age-adjusted | Median 23.1 | 1.1 (1.0-1.3) women as outcome | 1.1 (1.0-1.3) women as outcomec | Women’s age, education, occupation and family income |
Hippisley-Cox, 2002 | Cross-sectionalb | Trent, UK | 30-70 | Trent Focus Collaborative Research Practice Network; 29,014 | 8,386 | Electronic medical records; code for diabetes or current prescription of anti-hyperglycemic agents | 300 (3.6) | 156 (1.9) | Unclear | 1.70 (1.06, 2.74) women as outcome | 1.41 (0.87, 2.26) women as outcome | Women and men’s age, smoking status, GP practice clustering |
Hemminki, 2010 | Longitudinal cohort; 1972–2007; Mean follow-up 14.8 years | Sweden | >39 | Multigeneration and hospital discharge registers, 157,549 | 3,490,178 person-years | Hospital discharge summariesdiagnoses | 3,286 | 3,178 | Unclear | SIR 1.31 (1.26-1.35) men as outcome; 1.33 (1.29-1.38) women as outcome | N/A | Standardized to expected number of cases for age, sex, period, region and SES |
Khan, 2003 | Cross-sectionalb | London, UK | N/A; 57.4 (8.2) spouses of controls; 57.1 (7.2) spouses of participants with diabetes | Inner London GP diabetes clinic; 479 patients with diabetes for ≥5 years | 245 spouses of participants with diabetes; 234 spouses of controls | WHO criteria for diabetes diagnosis | 19 (7.8) spouses of diabetes patients; 7 (3.0) spouses of controls had diabetes. | Unclear | N/A | 2.11 (1.74-5.1) | None | |
 |  |  |  |  |  | Method of identifying pre-diabetes/diabetes | Pre-diabetes/diabetes prevalence a ; number (%) |  |  |  | ||
Khan, 2003 | See above | See above | See above | See above | See above | WHO criteria for diabetes, IGT and IFG diagnosis | 28 (11.4) spouses of diabetes patients; 15 (6.4) spouses of controls | Unclear | N/A | 2.32 (1.87, 3.98) | None | |
Kim, 2006 | Cross-sectional; 1998-2001 | Korea | ≥10; 47.9 (12.8) | Korean National Health and Nutrition Examination Surveys; 19,541 | 3,141 | FPG ≥6 mmol/L oranti-hyperglycemic medication | 530 (16.9) | Unclear | N/A | 1.92 (1.55, 2.37) women as outcome*; 1.94 (1.57, 2.40) men as outcome* | N/A |